FDA Drug Application (200435) for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE by TEVA PHARMS

Back to FDA Applications sponsored by TEVA PHARMS

Application Number200435
Product Number001
FormTABLET;ORAL
Dosage5MG;12.5MG;160MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
Active IngredientAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN



Back to FDA Applications sponsored by TEVA PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.